Rockwell Medical (RMTI) Change in Account Payables (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Change in Account Payables came in at $1.4 million in Q1 2026, up 253.18% YoY from $409425.3 in Q1 2025, and up 205.06% on a QoQ basis from $474000.0 in Q4 2025.
Rockwell Medical (RMTI) Change in Account Payables (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Change in Account Payables data on file, last reported at $1.4 million in Q1 2026.
- Quarterly Change in Account Payables rose 253.18% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (up 150.77% YoY) and the FY2025 annual result came in at -$870000.0, up 47.18% from the prior year.
- Change in Account Payables grew to $1.4 million in Q1 2026, from $474000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $1.4 million in Q1 2026 to a low of -$2.0 million in Q3 2023.
- A 5-year average of -$17294.1 and a median of $262000.0 in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2023 — Change in Account Payables plunged 1933.03% — and 2026, when it soared 253.18%.
- Tracing RMTI's Change in Account Payables over 5 years: stood at $1.0 million in 2022, then plunged by 41.42% to $587000.0 in 2023, then slumped by 55.37% to $262000.0 in 2024, then soared by 80.92% to $474000.0 in 2025, then soared by 205.06% to $1.4 million in 2026.
- The last three Change in Account Payables figures came in at $1.4 million (Q1 2026), $474000.0 (Q4 2025), and $23000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Rockwell Medical | 29.81 Mn | 5.01 Mn | 3.24 Mn | -266,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -266,000.00 |
| Jun 30, 2026 | -266,000.00 |
| Mar 31, 2026 | 1.45 Mn |
| Mar 31, 2026 | 1.45 Mn |
| Dec 31, 2025 | 474,000.00 |
| Dec 31, 2025 | 474,000.00 |
| Sep 30, 2025 | 23,000.00 |
| Sep 30, 2025 | 23,000.00 |
| Jun 30, 2025 | -423,000.00 |
| Jun 30, 2025 | -423,000.00 |
| Mar 31, 2025 | -944,000.00 |
| Mar 31, 2025 | -944,000.00 |
| Dec 31, 2024 | 262,000.00 |
| Dec 31, 2024 | 262,000.00 |
| Sep 30, 2024 | -740,000.00 |
| Sep 30, 2024 | -740,000.00 |
| Jun 30, 2024 | -1.57 Mn |
| Jun 30, 2024 | -1.57 Mn |
| Mar 31, 2024 | 403,000.00 |
| Mar 31, 2024 | 403,000.00 |